deepc and iCardio.ai Announce Partnership to Further Advance Cardiology Healthcare
deepc is pleased to announce a new partnership with iCardio.ai, an innovator in AI-driven ultrasound interpretation that has recently been awarded Breakthrough Designation by the FDA. This collaboration marks another milestone in deepc’s commitment to offering best-in-class AI solutions in medical imaging and further advances our aim to help revolutionize the field of cardiology.
The first iteration of iCardio.ai's Ultrasound OS enables automated echocardiogram interpretation. With features such as automated perspective classification, image quality assessment, and measurement of crucial heart parameters, iCardio.ai streamlines workflow processes and enhances precision in diagnosis.
By integrating this cutting-edge solution into clinical practice, healthcare professionals can expect to:
- Accelerate interpretation time by up to 3 times, unlocking unprecedented efficiency in patient care.
- Automate analysis for both normal and diseased patients, ensuring comprehensive support across a spectrum of cardiac conditions.
- Gain insights into study image quality and increase overall efficiency in echocardiographic interpretation workflow.
Joseph Sokol, CEO and Founder of iCardio.ai shares, “We are so excited to be partnering with deepc to distribute our artificial intelligence algorithms. deepc shares our vision for an AI future in healthcare, providing healthcare systems with easy access to this cutting-edge technology. Now, every deepc customer can take advantage of the automated tools we build here at iCardio.ai.“
deepc welcomes iCardio.ai to the deepcOS Radiology AI platform and looks forward to further unlocking the full potential of AI in transforming cardiac care together.
